Clinical Trial

A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2025 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228B in healthy subjects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-13.
Trial Details
NCT Number NCT06884098
Lead Sponsor Addpharma Inc.
Conditions Primary Hypercholesterolaemia
Enrollment 60 participants
Start Date 2025-03-10
Primary Completion 2025-04 (estimated)
Study Completion 2025-04 (estimated)
Updated on ClinicalTrials.gov 2025-03-20